Interleukin-12 Antagonist [EPC]

82504 reported adverse events

Drugs of this class: USTEKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 12048
1 OFF LABEL USE 9358
2 PRODUCT DOSE OMISSION ISSUE 6695
3 PSORIASIS 5640
4 FATIGUE 4541
5 PRODUCT USE ISSUE 4489
6 CROHN^S DISEASE 4295
7 PAIN 4087
8 ARTHRALGIA 3903
9 HEADACHE 3600
See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 799 0.6267
1 RHEUMATIC FEVER 963 0.5675
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 338 0.5559
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1986 0.4743
4 RHEUMATOID FACTOR POSITIVE 1672 0.4506
5 DUODENAL ULCER PERFORATION 1356 0.3474
6 FACET JOINT SYNDROME 319 0.3058
7 RETINITIS 201 0.2757
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 224 0.2517
9 PEMPHIGUS 2061 0.2454
See all enriched reactions for Interleukin-12 Antagonist [EPC]